97 related articles for article (PubMed ID: 11097866)
21. Regulation of the preprotachykinin-I gene promoter through a protein kinase A-dependent, cyclic AMP response element-binding protein-independent mechanism.
Calin-Jageman IE; Wang J; Bannon MJ
J Neurochem; 2006 Apr; 97(1):255-64. PubMed ID: 16515544
[TBL] [Abstract][Full Text] [Related]
22. Transcription factor activator protein-1 expressed by kainate treatment can bind to the non-coding region of mitochondrial genome in murine hippocampus.
Ogita K; Fujinami Y; Kitano M; Yoneda Y
J Neurosci Res; 2003 Sep; 73(6):794-802. PubMed ID: 12949905
[TBL] [Abstract][Full Text] [Related]
23. MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability.
Cuevas BD; Uhlik MT; Garrington TP; Johnson GL
Oncogene; 2005 Jan; 24(5):801-9. PubMed ID: 15558021
[TBL] [Abstract][Full Text] [Related]
24. Lipopolysaccharide regulates constitutive and inducible transcription factor activities differentially in vivo in the rat.
Ye X; Liu SF
Biochem Biophys Res Commun; 2001 Nov; 288(4):927-32. PubMed ID: 11688998
[TBL] [Abstract][Full Text] [Related]
25. Sodium arsenite downregulates transcriptional activity of AP-1 and CRE binding proteins in IL-1beta-treated Caco-2 cells by increasing the expression of the transcriptional repressor CREMalpha.
Hershko DD; Robb BW; Luo GJ; Hungness ES; Hasselgren PO
J Cell Biochem; 2003 Oct; 90(3):627-40. PubMed ID: 14523996
[TBL] [Abstract][Full Text] [Related]
26. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
27. Novel mechanism of protein kinase C inhibition involving the pseudosubstrate region by secalonic acid D in vitro.
Balasubramanian G; Reddy CS
Toxicol Appl Pharmacol; 2000 Feb; 163(1):86-93. PubMed ID: 10662608
[TBL] [Abstract][Full Text] [Related]
28. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
29. The c-Jun NH(2)-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine.
Fan M; Goodwin ME; Birrer MJ; Chambers TC
Cancer Res; 2001 Jun; 61(11):4450-8. PubMed ID: 11389075
[TBL] [Abstract][Full Text] [Related]
30. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells.
Iwai K; Mori N; Oie M; Yamamoto N; Fujii M
Virology; 2001 Jan; 279(1):38-46. PubMed ID: 11145887
[TBL] [Abstract][Full Text] [Related]
31. Expression and distribution of AP-1 transcription factors in the porcine ovary.
Rusovici R; LaVoie HA
Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371
[TBL] [Abstract][Full Text] [Related]
32. Hepatocyte growth factor activates the AP-1 complex: a comparison between normal and transformed rat hepatocytes.
Rahmani M; Nadori F; Durand-Schneider AM; Lardeux B; Bernuau D
J Hepatol; 1999 May; 30(5):916-25. PubMed ID: 10365821
[TBL] [Abstract][Full Text] [Related]
33. Impaired AP-1 dimers and NFAT complex formation in immature thymocytes during in vivo glucocorticoid-induced apoptosis.
Wisniewska M; Pyrzynska B; Kaminska B
Cell Biol Int; 2004; 28(11):773-80. PubMed ID: 15563399
[TBL] [Abstract][Full Text] [Related]
34. Selective inhibition of murine palatal mesenchymal cell proliferation in vitro by secalonic acid D.
Hanumegowda UM; Judy BM; Welshons WV; Reddy CS
Toxicol Sci; 2002 Mar; 66(1):159-65. PubMed ID: 11861983
[TBL] [Abstract][Full Text] [Related]
35. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
36. CREB mediates UTP-directed arterial smooth muscle cell migration and expression of the chemotactic protein osteopontin via its interaction with activator protein-1 sites.
Jalvy S; Renault MA; Lam Shang Leen L; Belloc I; Reynaud A; Gadeau AP; Desgranges C
Circ Res; 2007 May; 100(9):1292-9. PubMed ID: 17413042
[TBL] [Abstract][Full Text] [Related]
37. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
Chun KS; Kim SH; Song YS; Surh YJ
Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
[TBL] [Abstract][Full Text] [Related]
38. Oxidized LDL induces transcription factor activator protein-1 in rat mesangial cells.
Wu ZL; Wang YC; Zhou Q; Ge YQ; Lan Y
Cell Biochem Funct; 2003 Sep; 21(3):249-56. PubMed ID: 12910478
[TBL] [Abstract][Full Text] [Related]
39. Phorbol ester treatment of human myometrial cells suppresses expression of oxytocin receptor through a mechanism that does not involve activator protein-1.
Ball A; Wang JW; Wong S; Zielnik B; Mitchell J; Wang N; Stemerman MB; Mitchell BF
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E922-8. PubMed ID: 16757545
[TBL] [Abstract][Full Text] [Related]
40. Role of maternal plasma corticosterone elevation in the teratogenicity of secalonic acid D in mice.
Eldeib MM; Reddy CS
Teratology; 1990 Feb; 41(2):137-46. PubMed ID: 2321159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
